ATLANTA, Aug. 02, 2023 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. ALIM (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will report second quarter financial results on August 10, 2023,…Read More
Alimera Sciences to Report Second Quarter 2023 Financial Results on August 10 2023 and Provide Corporate Update Alimera Sciences NASDAQALIM
